IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

What happened

IRADIMED CORPORATION reported third quarter 2026 revenue of $24.2 million, up 14% from a year earlier and 18% from the second quarter. It declared a regular quarterly cash dividend of $0.20 per share, payable November 27, 2026.

Confirmed

Global impact / market context

Higher revenue and a steady dividend of $0.20 per share suggest the company is selling more MRI-compatible devices while still returning cash to shareholders. Rising sales of the new 3870 MR IV pump mean more money coming in, which can support manufacturing and future products.

Analyst inference

Investors often compare revenue growth and profit per share across quarters to judge momentum. Here, growth came from a new pump platform, while the dividend signals cash available to return. Manufacturing ramp-up costs could pressure profit per sale as production scales.

Analyst inference

What to watch

1. Quarterly dividend of $0.20 per share is payable on November 27, 2026, so watch whether the company keeps paying it at this level in later quarters. Confirmed
2. Watch whether the new 3870 MR IV pump launch keeps lifting revenue, since the company said growth was driven by this product and production is ramping up. Proposed
3. Watch manufacturing costs as production of the new pump increases, because greater output can lower profit per sale if expenses rise faster than revenue. Analyst inference

Evidence

• globenewswire.com